These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 23661792)

  • 41. Global eradication of poliomyelitis: reinvent the wheel or use existing options effectively?
    Ogra PL
    Public Health Rev; 1993-1994; 21(1-2):143-50. PubMed ID: 8041881
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative study of poliovirus excretion after vaccination of infants with two oral polio vaccines prepared on Vero cells or on primary monkey kidney cells.
    Mallet L; Pelloquin F; Brigaud M; Caudrelier P; Bandet R; Xueref C; Fuchs F; Gibelin N; Goldman C; Moulin JC; de Fraipont F; Montagnon B; Peyron L; Aymard M
    J Med Virol; 1997 May; 52(1):50-60. PubMed ID: 9131458
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Limited duration of vaccine poliovirus and other enterovirus excretion among human immunodeficiency virus infected children in Kenya.
    Khetsuriani N; Helfand R; Pallansch M; Kew O; Fowlkes A; Oberste MS; Tukei P; Muli J; Makokha E; Gary H
    BMC Infect Dis; 2009 Aug; 9():136. PubMed ID: 19698184
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mucosal immunity after vaccination with monovalent and trivalent oral poliovirus vaccine in India.
    Grassly NC; Jafari H; Bahl S; Durrani S; Wenger J; Sutter RW; Aylward RB
    J Infect Dis; 2009 Sep; 200(5):794-801. PubMed ID: 19624278
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Isolates of poliovirus vaccine and immune response to different doses of oral polio vaccine].
    Más Lago P; Díaz J; Díaz Gonzalez M; Goyenechea Hernández A; Barrio Olivera J; Fonseca Quintana M; Morier Díaz L; Sarmiento Pérez L; Palomera Puente R
    Rev Cubana Med Trop; 2005; 57(2):111-9. PubMed ID: 17966580
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anomalous observations on IPV and OPV vaccination.
    John TJ
    Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Kinetics of poliovirus shedding following oral vaccination as measured by quantitative reverse transcription-PCR versus culture.
    Taniuchi M; Begum S; Uddin MJ; Platts-Mills JA; Liu J; Kirkpatrick BD; Chowdhury AH; Jamil KM; Haque R; Petri WA; Houpt ER
    J Clin Microbiol; 2015 Jan; 53(1):206-11. PubMed ID: 25378579
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Validation of a High-throughput, Multiplex, Real-time Qualitative Polymerase Chain Reaction Assay for the Detection of Sabin Oral Polio Vaccine in Environmental Samples.
    Altamirano J; Leary S; van Hoorebeke C; Sarnquist C; Behl R; García-García L; Ferreyra-Reyes L; Huang C; Sommer M; Maldonado Y
    Clin Infect Dis; 2018 Oct; 67(suppl_1):S98-S102. PubMed ID: 30376093
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Poliovirus excretion following vaccination with live poliovirus vaccine in patients with primary immunodeficiency disorders: clinicians' perspectives in the endgame plan for polio eradication.
    Galal NM; Meshaal S; ElHawary R; Nasr E; Bassiouni L; Ashghar H; Farag NH; Mach O; Burns C; Iber J; Chen Q; ElMarsafy A
    BMC Res Notes; 2018 Oct; 11(1):717. PubMed ID: 30305145
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intestinal immunity following a combined enhanced inactivated polio vaccine/oral polio vaccine programme in Israel.
    Swartz TA; Green MS; Handscher R; Sofer D; Cohen-Dar M; Shohat T; Habib S; Barak E; Dror Z; Somekh E; Peled-Leviathan T; Yulzari R; Libling A; Mendelson E; Shulman LM
    Vaccine; 2008 Feb; 26(8):1083-90. PubMed ID: 18241962
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Exploring the relationship between polio type 2 serum neutralizing antibodies and intestinal immunity using data from two randomized controlled trials of new bOPV-IPV immunization schedules.
    Bandyopadhyay AS; Asturias EJ; O'Ryan M; Oberste MS; Weldon W; Clemens R; Rüttimann R; Modlin JF; Gast C
    Vaccine; 2017 Dec; 35(52):7283-7291. PubMed ID: 29150209
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New insights into physiopathology of immunodeficiency-associated vaccine-derived poliovirus infection; systematic review of over 5 decades of data.
    Shaghaghi M; Soleyman-Jahi S; Abolhassani H; Yazdani R; Azizi G; Rezaei N; Barbouche MR; McKinlay MA; Aghamohammadi A
    Vaccine; 2018 Mar; 36(13):1711-1719. PubMed ID: 29478755
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative evaluation of immunization with live attenuated and inactivated poliovirus vaccines.
    Ogra PL
    Ann N Y Acad Sci; 1995 May; 754():97-107. PubMed ID: 7625685
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of diarrheal disease on bivalent oral polio vaccine (bOPV) immune response in infants in Nepal.
    Cardemil CV; Estivariz C; Shrestha L; Sherchand JB; Sharma A; Gary HE; Oberste MS; Weldon WC; Bowen MD; Vinjé J; Schluter WW; Anand A; Mach O; Chu SY
    Vaccine; 2016 May; 34(22):2519-26. PubMed ID: 27085172
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Poliovirus Excretion in Children with Primary Immunodeficiency Disorders, India.
    Mohanty MC; Madkaikar MR; Desai M; Taur P; Nalavade UP; Sharma DK; Gupta M; Dalvi A; Shabrish S; Kulkarni M; Aluri J; Deshpande JM
    Emerg Infect Dis; 2017 Oct; 23(10):1664-1670. PubMed ID: 28930011
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Deep sequencing prompts the modification of a real-time RT-PCR for the serotype-specific detection of polioviruses.
    Holubar M; Sahoo MK; Huang C; Mohamed-Hadley A; Liu Y; Waggoner JJ; Troy SB; García-García L; Ferreyra-Reyes L; Maldonado Y; Pinsky BA
    J Virol Methods; 2019 Feb; 264():38-43. PubMed ID: 30447245
    [TBL] [Abstract][Full Text] [Related]  

  • 57. OPV Vaccination and Shedding Patterns in Mexican and US Children.
    Altamirano J; Sarnquist C; Behl R; García-García L; Ferreyra-Reyes L; Leary S; Maldonado Y
    Clin Infect Dis; 2018 Oct; 67(suppl_1):S85-S89. PubMed ID: 30376085
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Spatial Analyses of Oral Polio Vaccine Transmission in an Community Vaccinated With Inactivated Polio Vaccine.
    Jarvis CI; Altamirano J; Sarnquist C; Edmunds WJ; Maldonado Y
    Clin Infect Dis; 2018 Oct; 67(suppl_1):S18-S25. PubMed ID: 30376089
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comprehensive screening for immunodeficiency-associated vaccine-derived poliovirus: an essential oral poliovirus vaccine cessation risk management strategy.
    Duintjer Tebbens RJ; Thompson KM
    Epidemiol Infect; 2017 Jan; 145(2):217-226. PubMed ID: 27760579
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oral iodine supplementation does not reduce neutralizing antibody responses to oral poliovirus vaccine.
    Taffs RE; Enterline JC; Rusmil K; Muhilal ; Suwardi SS; Rustama D; Djatnika ; Cobra C; Semba RD; Cohen N; Asher DM
    Bull World Health Organ; 1999; 77(6):484-91. PubMed ID: 10427933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.